Staphylococcus aureus Infections: Epidemiology, Pathophysiology, Clinical Manifestations, and Management

被引:3301
|
作者
Tong, Steven Y. C. [1 ]
Davis, Joshua S. [1 ]
Eichenberger, Emily [2 ]
Holland, Thomas L. [2 ]
Fowler, Vance G., Jr. [2 ,3 ]
机构
[1] Menzies Sch Hlth Res, Global & Trop Hlth, Darwin, NT, Australia
[2] Duke Univ, Med Ctr, Dept Med, Div Infect Dis, Durham, NC 27710 USA
[3] Duke Univ, Med Ctr, Duke Clin Res Inst, Durham, NC USA
基金
美国国家卫生研究院;
关键词
SMALL-COLONY VARIANTS; PANTON-VALENTINE LEUKOCIDIN; PROSTHETIC VALVE ENDOCARDITIS; SKIN-STRUCTURE INFECTIONS; SPINAL EPIDURAL ABSCESS; TOXIC-SHOCK-SYNDROME; SOFT-TISSUE INFECTIONS; BLOOD-STREAM INFECTIONS; ACUTE BACTERIAL SKIN; COMMUNITY-ACQUIRED PNEUMONIA;
D O I
10.1128/CMR.00134-14
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Staphylococcus aureus is a major human pathogen that causes a wide range of clinical infections. It is a leading cause of bacteremia and infective endocarditis as well as osteoarticular, skin and soft tissue, pleuropulmonary, and device-related infections. This review comprehensively covers the epidemiology, pathophysiology, clinical manifestations, and management of each of these clinical entities. The past 2 decades have witnessed two clear shifts in the epidemiology of S. aureus infections: first, a growing number of health care-associated infections, particularly seen in infective endocarditis and prosthetic device infections, and second, an epidemic of community-associated skin and soft tissue infections driven by strains with certain virulence factors and resistance to beta-lactam antibiotics. In reviewing the literature to support management strategies for these clinical manifestations, we also highlight the paucity of high-quality evidence for many key clinical questions.
引用
收藏
页码:603 / 661
页数:59
相关论文
共 50 条
  • [1] THE CHANGING EPIDEMIOLOGY AND PATHOPHYSIOLOGY OF STAPHYLOCOCCUS AUREUS INFECTIONS IN THE USA
    Daum, R. S.
    CHILD CARE HEALTH AND DEVELOPMENT, 2010, 36 : 37 - 38
  • [2] Staphylococcus aureus Bacteremia: Epidemiology, Pathophysiology, and Management Strategies
    Naber, Christoph K.
    CLINICAL INFECTIOUS DISEASES, 2009, 48 : S231 - S237
  • [3] Staphylococcus aureus epidemiology, pathophysiology, clinical manifestations and application of nano-therapeutics as a promising approach to combat methicillin resistant Staphylococcus aureus
    Bashabsheh, Raghad H. F.
    AL-Fawares, O'la
    Natsheh, Iyad
    Bdeir, Roba
    Al-Khreshieh, Rozan O.
    Bashabsheh, Hasan H. F.
    PATHOGENS AND GLOBAL HEALTH, 2024, 118 (03) : 209 - 231
  • [4] The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji
    Jenney, Adam
    Holt, Deborah
    Ritika, Roselyn
    Southwell, Paul
    Pravin, Shalini
    Buadromo, Eka
    Carapetis, Jonathan
    Tong, Steven
    Steer, Andrew
    BMC INFECTIOUS DISEASES, 2014, 14
  • [5] The clinical and molecular epidemiology of Staphylococcus aureus infections in Fiji
    Adam Jenney
    Deborah Holt
    Roselyn Ritika
    Paul Southwell
    Shalini Pravin
    Eka Buadromo
    Jonathan Carapetis
    Steven Tong
    Andrew Steer
    BMC Infectious Diseases, 14
  • [6] Obesity and heart failure: epidemiology, pathophysiology, clinical manifestations, and management
    Alpert, Martin A.
    Lavie, Carl J.
    Agrawal, Harsh
    Aggarwal, Kul B.
    Kumar, Senthil A.
    TRANSLATIONAL RESEARCH, 2014, 164 (04) : 345 - 356
  • [7] New epidemiology of Staphylococcus aureus infections
    Rasigade, J-P
    Dumitrescu, O.
    Lina, G.
    CLINICAL MICROBIOLOGY AND INFECTION, 2014, 20 (07) : 587 - 588
  • [8] Methicillin-Resistant Staphylococcus aureus Prosthetic Valve Endocarditis: Pathophysiology, Epidemiology, Clinical Presentation, Diagnosis, and Management
    Galar, Alicia
    Weil, Ana A.
    Dudzinski, David M.
    Munoz, Patricia
    Siedner, Mark J.
    CLINICAL MICROBIOLOGY REVIEWS, 2019, 32 (02)
  • [9] Management of Staphylococcus aureus infections
    Bamberger, DM
    Boyd, SE
    AMERICAN FAMILY PHYSICIAN, 2005, 72 (12) : 2474 - 2481
  • [10] Epidemiology, clinical features and management of infections due to community methicillin-resistant Staphylococcus aureus (cMRSA)
    Gosbell, IB
    INTERNAL MEDICINE JOURNAL, 2005, 35 : S120 - S135